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ABSTRACT
Introduction: Over 80% of very preterm (<32 weeks)
and very low birthweight (<1500 g) infants will have
either typical development (TD) or mild developmental
delay (MDD) in multiple domains. As differentiation
between TD and MDD can be difficult, infants with
MDD often miss opportunities for intervention. For
many clinicians, the ongoing challenge is early
detection of MDD without over servicing the
population. This study aims to: (1) identify early
clinical biomarkers for use in this population
to predict and differentiate between TD and
MDD at 24 months corrected age. (2) Determine the
extent to which family and caregiver factors will
contribute to neurodevelopmental and behavioural
outcomes.
Methods and analysis: Participants will be a
prospective cohort of 90 infants (<32 weeks and/or
<1500 g). Between 34 weeks gestational age and
16 weeks post-term, infants will have a series of
5 neurological, neuromotor, neurobehavioural and
perceptual assessments including General Movement
Assessment at preterm, writhing and fidgety age.
Primary caregivers will complete questionnaires to
identify social risk, maternal depression and family
strain. Extensive perinatal data will be collected from
the medical record. At 24 months, corrected age (c.a)
infants will be assessed using standardised tools
including the Bayley Scales of Infant and Toddler
Development—Third Edition (Bayley III). Longitudinal
trajectories of early assessment findings
will be examined to determine any predictive
relationship with motor and cognitive outcomes at
24 months c.a. Published data of a cohort of
Australian children assessed with the Bayley III at
24 months c.a will provide a reference group
of term-born controls.
Ethics: Ethical approval has been obtained from the
Queensland Children’s Health Services Human
Research Ethics Committee (HREC/13/QRCH/66), the
University of Queensland (2013001019) and the
Sunshine Coast Hospital and Health Service,
SC-Research Governance (SSA/13/QNB/66).
Publication of all study outcomes will be in peer-
reviewed journals.
Trial registration number: ACTRN12614000480684;
Pre-results.
INTRODUCTION
The absolute number of children born very
preterm and very low birth weight (VLBW) is
increasing in developed countries as neo-
natal intensive care continues to improve.1 2
As survival rates increase, the focus moves to
consideration of quality of life.1–8 The inci-
dence of severe outcomes in the very
preterm/VLBW population is beginning to
decline but the overall risk of developmental
delay across multiple domains remains steady
at 47%.2 5 9 10 With rates of typical outcome
at ∼52%, clinical practitioners are now chal-
lenged by the need to differentiate between
infants with mild delay and TD.1 2 5 11
Given the current pressure on public
health resources, population intervention is
no longer practical nor cost-efficient. Robust
early prediction and differentiation is war-
ranted to prevent overservicing of very
preterm/VLBW infants who are typically
developing and facilitate targeted interven-
tions for infants in the population with
higher risk for developmental delay.
In Australia, very preterm children with
mild deficits are less likely to receive services
than children with more severe outcomes.12
Lack of service engagement is even more
evident for very preterm children living in
situations of higher social or environmental
risk.12 This is cause for concern as early
delays do not dissipate, rather they become
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more apparent with age alongside increasing functional
demands in educational and social contexts.4 6 7 13–16
Late referral often means that infants completely miss
out on vital input during critical periods of development
when enriched experiences provided by parents and
therapists may optimise neuroplasticity.17 18
Mild impairment in VLBW and very preterm infants
Children born very preterm have an increased risk of
mild motor delay (MMD) not associated with cerebral
palsy (CP).19 Prevalence of MMD in children born
preterm is three to four times greater than in term-born
infants.8 19 At 8–12 months corrected age (c.a) nearly
half of very preterm infants (47%) have mildly delayed
scores on the Gross Motor Subscale of the Bayley Scales
of Infant and Toddler Development—Third Edition
(Bayley III).20 At 2.5 years c.a, 29% of children score
1SD below the control mean on the gross motor and
34% on the fine motor scale of the Bayley III.21 Studies
at school age show similar outcomes with one study
reporting 32% and another 50% of very preterm-born
children scoring ≤15th centile on the Movement
Assessment Battery for Children (MABC) at 5 years c.a.7
Consistent findings of mild delay in the preterm popu-
lation from birth to 5 years suggest that motor delays do
not improve with time. Instead, early delays progress to
motor impairments at school entry that then persist into
adolescence.4 22 Developmental coordination disorder is
highly prevalent in the VLBW/very preterm population
with children six times more likely to score at or below
the 5th centile on the MABC, and eight times more
likely to score below the 15th centile.14 A meta-analysis
of 41 articles encompassing 9653 very preterm/VLBW
children from infancy to 15 years found that on average,
these children are −0.57SD to −0.88SD behind their
term-born peers or typically developing children in
motor development.4
Mild motor impairment is rarely experienced in isola-
tion. Children who are born very preterm or VLBW are
more likely than term-born infants to perform below
average in two or more developmental
domains.5 6 7 20 21 Comorbidities that frequently accom-
pany MMD include mild deficits and delay in the cogni-
tive, communication, behavioural, personal–social and
perceptual domains including sensory processing differ-
ences.1 5–7 9–11 20–24 In very preterm infants where
motor delay is identified at 5 years of age, there is a sub-
stantially higher rate of impairment in other domains
compared with very preterm infants who do not have
motor impairment.7 Deficits associated with MMD at
this age include lower IQ, decreased processing speed,
poor visuomotor coordination and increased incidence
of complex minor neurological dysfunction.7
Biological rationale for multidomain neurodevelopmental
deficits
Preterm birth is timed against a background of signifi-
cant maturational processes. Between 24 and 40 weeks
gestation, multiple developmental events are taking
place that include the preoligodendrocytes, microglia,
axons, subplate neurons, germinal epithelium of the
ganglionic eminence, thalamus, cortex and cerebel-
lum.25 Add to this the fragility of a nervous system not
prepared for the impact of the extrauterine environ-
ment and the result is an immature and actively develop-
ing brain vulnerable to insults such as hypoxia,
inflammation, ischaemia, excitotoxicity and free radical
attack.25–28
The high vascularity of the germinal matrix makes it
prone to congestion and its fragile capillary system is vul-
nerable to damage from hypoxia, fluctuations in blood
flow velocity and venous congestion. The resulting
haemorrhage may leak into the adjacent ventricles or
even further into the surrounding white matter. In
severe cases, there may be persisting hydrocephalus.28
In periventricular leucomalacia, hypoxia causes activa-
tion of microglia leading to secretion of toxic oxygen
and nitrogen radicals and the release of glutamate.
Inflammation secondary to maternal, placental or fetal
infection sets in motion the same reaction, releasing the
same toxins produced with hypoxia.25 28 The principle
target of these free radicals and glutamate are the pre-
myelinating oligodendrocytes. Cell loss at this crucial
stage results in a deficit of mature oligodendrocytes and
impairment of myelination.25 27 28 There may be accom-
panying axonal injury resulting in loss and disarray of
axons and damage to subplate neurons that will impair
connections between the thalamus and cortex.25 26
The outcome of this widespread and multifaceted
primary and secondary brain injury is impaired white
matter development and a decrease in total brain
volumes persisting through childhood and into adoles-
cence.18 25 26 29 30 On average, brain volume in very
preterm/VLBW infants is 0.58SD lower than in term
children, with white matter volume reductions of 0.53SD
and grey matter volume reductions of 0.62SD.
Reductions are seen in cerebellar volumes, hippocampal
volumes and the size of the corpus callosum as well as
reduced volumes of the thalamus and basal ganglia.26
It is becoming evident that motor, cognitive and per-
ceptual deficits may be more inter-related than previ-
ously appreciated.26 31 The thalamus and cerebellum,
particularly vulnerable to preterm insult, appear to be
vital nodes in brain networks playing important roles in
cognitive, motor and perceptual tasks.31 32 Early impacts
to the cerebellum may result in impairment of motor
control as well as cognitive ability to learn or organise
tasks that are new, difficult, unpredictable, require con-
centration or need quick responses.31
Damage to the thalamus will potentially impact atten-
tion, awareness, visually guided actions and perceptual
matching of visual space across eye movement.32 33 It
may also compromise memory and cognition including
the cognitive aspects of motor control.34 35 White matter
damage to the posterior thalamic radiations, the corpus
callosum, basal ganglia and superior longitudinal
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fasciculus is strongly correlated with atypical unimodal
and multisensory integration manifest in sensory pro-
cessing disorders.36 The thalamus also acts with the
basal ganglia as a central monitor for language-specific
cortical activities and injury may impact on perceptual
and productive language execution.37
In summary, the interactions occurring between
neurological development and biological disturbance in
the very preterm/VLBW infant brain are complicated
and variable. There are many potential mechanisms for
negative impacts on neural structures and connections
that are crucial for organisation and coordination of
multiple tasks and functions. Subsequently, it is hypothe-
sised that prediction of typical and mildly delayed motor
and cognitive outcomes at 24 months c.a will require a
combination of fit for purpose clinical tools used across
the early developmental trajectory to assess the neuro-
logical, neuromotor, neurobehavioral and perceptual
functions.
Social risk and environmental impact
The International Classification of Functioning, Disability
and Health clearly indicates that contextual factors have
an important influence on activity level and participa-
tion.38 The very preterm/VLBW infant’s developmental
outcome is dependent on many variables, including social
and environmental influences.1 11 16 19 39 The impact of
gestational age (g.a), perinatal factors and biological insult
is mitigated by level of maternal/parental education.22 40
Lower socioeconomic status (SES) is also associated with a
poorer developmental outcome.12 16 39 40 Children with
lower SES have significantly lower composite scores on the
cognitive, language and motor indices of the Bayley III
than children with higher SES.16
Premature birth is a stressful event with negative psy-
chological and emotional effects on the family.41 This
effect is greatest in the first month of life and remains a
substantial burden.1 42 At 7 years of age, parents of very
preterm children report higher levels of total parenting
stress, total parent-related stress and total child-related
stress as well as poorer family functioning when com-
pared with families of term-born infants.42 As higher
rates of stress are associated with lower SES and lower
parental education, stress can compound pre-existing
environmental and social risk factors.1 An important
aim of this study is to investigate the extent to which
family and caregiver factors will contribute to develop-
mental outcome.
The need for early biomarkers
By definition, a biomarker, or ‘biological marker’, is an
objective indicator of medical state observed from
outside the patient which can be measured accurately
and reproducibly.43 Biomarkers are used to monitor and
predict health states in individuals or across populations,
so that appropriate therapeutic intervention can be
planned. They can be used separately or in combination
to provide a detailed picture of how healthy a person is
and whether or not a diagnosis needs to be made.44
Biomarkers are used to predict both the healthy and the
disease state.43 44 They should be fit for purpose, safe
and easy to measure, cost-efficient, modifiable with treat-
ment, and consistent across gender and ethnic
groups.44 45
The risk of developmental delay in the preterm popu-
lation increases exponentially as g.a decreases.6 11 There
is no particular threshold below which risk starts to
increase and no g.a that is wholly exempt.1 6 As the
causative pathway for developmental delay is multifa-
ceted and there are increasing numbers of infants to
consider, clinicians need early biomarkers they can rely
on to accurately predict outcomes in order to efficiently
and effectively prioritise early intervention services.11
There is no single standardised neurodevelopmental
assessment tool, or combination of tools, currently advo-
cated or recognised as the ‘gold standard’ for use with
infants in the early months of life to predict typical
outcome and mild delay at 24 months c.a.46 Instead
there are numerous assessments that vary in their physio-
logical basis, pre-requisite training and expertise, time
allotted to perform and score, and clinical utility and
validity.45 47 48 Few of these clinical tools are well suited
for use with fragile or sick VLBW/very preterm neonates
or in clinical rather than research settings.48 49
In this study, our plan is to explore the potential of
five clinical tests, used in combination across the early
developmental trajectory, to act as biomarkers for typical
and mild outcome in the motor and cognitive domains
for very preterm and VLBW infants at 24 months c.a.
Ideally, tools that are predictive, valid, safe and easy to
administer are a good fit for developmental follow-up in
neonatal intensive care, special care, outpatient and
community follow-up programmes. Tools that can be
used during routine clinical contact offer an easily admi-
nistered, resource-efficient means of early detection and
provide important opportunities for earlier referral to
intervention services.50
The General Movements (GMs) Assessment of spon-
taneous movement is the most predictive clinical test of
neuromotor function available for use between birth
and 20 weeks post-term.45 48 The assessment is purely
observational and easily administered in clinical settings.
Longitudinal assessment of GMs from 34 until 16 weeks
post-term will be combined with four other assessment
measures: a preterm neurological/neurobehavioural
assessment, a neurobehavioural assessment at 2 weeks
c.a, and then motor and perceptual function assessment
at 16 weeks post-term.
The Premie-Neuro Examination (P-NE) neurological/
neurobehavioural assessment is selected for inclusion at
34 weeks based on excellent clinical utility for use with
very preterm infants. It is the only preterm neuro-
logical/neurobehavioral assessment with standardised
norms from 23 to 37 weeks g.a. Early research suggests
evidence of ability to discriminate between high-risk and
low-risk infants.49 51
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The Neonatal Intensive Care Unit Network
Neurobehavioral Scale (NNNS) will be included at
2 weeks post-term. The NNNS is a neurobehavioural
assessment specifically developed for use with ‘at-risk’
and preterm infants.52 When used at term equivalent
age it has demonstrated ability to predict motor, cogni-
tive, behavioural and school readiness outcomes
between 18 months and 4.5 years.53–55
The Alberta Infant Motor Scale (AIMS) is included as
the motor assessment with the best combination of clin-
ical utility and predictive validity for outcomes in the
second year of life at 16 weeks post-term.45 The Infant
Sensory Profile 2 (Infant SP2) is a short parent question-
naire and recent revision of the Infant Toddler Sensory
Profile (ITSP).56 57 It is included as the best sensory pro-
cessing measure available for use from birth.58
Broad aim
The primary aim of this study is to identify clinical bio-
markers that can be used between preterm birth and
16 weeks post-term to accurately predict typical develop-
ment and mild developmental delay in the very preterm
and VLBW population at 24 months c.a. Clinicians need
reliable biomarkers to make earlier accurate prediction
of outcomes to improve prioritisation and promote
timely service delivery. A logical strategy is to predict
normal outcome and then direct resources towards the
smaller pool of ‘at-risk’ infants. The next step is to
predict mild delay as distinct from typical and severe out-
comes. As mild delay is the result of complex, inter-
twined, biological and environmental variables, a
combination of biomarkers used across the developmen-
tal trajectory is most likely to correlate with later
outcomes.
The secondary aim of this study is to determine the
extent to which family and caregiver factors including
social risk, maternal mental health, and education and
family strain will contribute to neurodevelopmental and
behavioural outcomes at 24 months c.a.
Primary hypothesis
Key clinical biomarkers used to assess the developmental
trajectory of neurological, neurobehavioural, neuromo-
tor and perceptual function between 34 weeks g.a and
16 weeks post-term will allow accurate prediction of
typical outcome and mild developmental delay in the
motor and cognitive domains at 24 months c.a.
OVERVIEW OF AIMS
Aim 1
To assess the ability of five clinical assessments, GMs,
P-NE, NNNS, AIMS and the Infant SP2, administered
between 34 weeks g.a and 16 weeks post-term, to predict
typical outcomes and mild motor and cognitive delay at
24 months c.a.
Typical outcome is defined as motor and cognitive
composite scores no lower than 1SD below the mean on
the Bayley III. Mild developmental delay is defined as
scores between 1SD and 2SD below the mean, moderate
delay by scores between 2SD and 3SD below the mean
and severe delay as scores more than 3SD below the
mean.5
Typical outcome on the Neuro-Sensory and Motor
Developmental Assessment (NSMDA) is defined as a
motor classification score of 1 or 2.59 A score of 1 is
defined as within normal limits, a score of 2 as minimal
deviation not impacting function. Developmental delay
on the NSMDA is defined as a motor classification score
>2. A score of 3 indicates a mild dysfunction requiring
treatment, 4 indicates moderate disability, 5 severe dis-
ability and a score of 6 indicates profound
impairment.59
Hypotheses
H1a. Higher raw scores on the P-NE (>95) combined
with a ‘low-risk’ trajectory of GMs, typical profile on the
NNNS subscales (10th to 90th centiles) and a normal
classification on the AIMS (>10th centile) will predict
typical performance (scores above −1SD) on the motor
and cognitive subscales of the Bayley III at 24 months c.a
and a functional grade of 1or 2 on the NSMDA.46 51
H1b. Lower scores on the P-NE (<95), combined with a
‘moderate-risk’ or ‘high-risk’ trajectory of GMs, atypical
profile on the NNNS subscales (centile <10 or >90) and
a suspicious/abnormal classification on the AIMS (<10th
centile) will predict scores −1SD or more below the
mean on the motor and cognitive subscales of the
Bayley III at 24 months c.a and a functional grade >2 on
the NSMDA.
H1c. Children identified with mild delays (between
−1SD and −2SD below the mean) on the cognitive and
motor subscales of the Bayley III subscale will be more
likely to have lower scores (−1SD or more below the
mean) on the language, adaptive behaviour and social
emotional subscales of the Bayley III.
H1d. A typical sensory profile on the Infant SP2 at
16 weeks post-term will be associated with typical motor
and cognitive outcomes outcome on the Bayley III at
24 months c.a.
Aim 2
To examine any associations between the PN-E neuro-
logical examination and GMs at preterm and between
the PN-E at preterm and longitudinal classification of
GM trajectories at 16 weeks post-term. To further deter-
mine any predictive association between the PN-E at
preterm, the NNNS at 2 weeks post-term and the AIMS
and Infant SP2 at 16 weeks post-term.
Hypotheses
H2a. Higher raw scores on the PN-E at 34–35 weeks g.a
(>95) will correlate with normal GMs classification at
34–35 weeks g.a. Lower raw scores on the PN-E at 34–
35 weeks g.a will correlate with poor repertoire and
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cramped synchronised classification on the GMs at 34–
35 weeks g.a.
H2b. Raw scores on the PN-E at 34–35 weeks g.a will
predict subscale scores on the NNNS (typical or atyp-
ical) at 2 weeks post-term.
H2c. Raw scores on the PN-E at 34 weeks will predict clas-
sification of risk on GM trajectories (low, moderate,
high), classification on the AIMS (normal, suspicious/
abnormal) and typical or atypical sensory processing on
the Infant SP2 at 16 weeks post-term.
Aim 3
To determine any predictive association between the
NNNS at 2 weeks post-term and GM classification at
16 weeks post-term. To further determine any association
between the NNNS at 2 weeks post-term and the AIMS
and Infant SP2 at 16 weeks post-term.
Hypothesis
H3a. Subscale scores on the NNNS at 2 weeks post-term
(typical or atypical) will predict classification of risk on
GM trajectories (low, moderate, high), classification on
the AIMS (normal, suspicious/abnormal) and typical or
atypical sensory processing on the Infant SP2 at
16 weeks post-term.
Aim 4
To determine any predictive association between the
NNNS at 2 weeks post-term and behavioural outcome at
24 months c.a (Bayley III, Infant-Toddler Social-Emotional
Assessment (ITSEA)). To further determine any associ-
ation between the NNNS at 2 weeks post-term and sensory
profile at 24 months c.a.
Hypothesis
H4a. Subscale scores on the NNNS (typical or atypical)
at 2 weeks post-term will predict behavioural and
social emotional competencies on the ITSEA and typical
or atypical sensory profile on the Infant SP2 at
24 months c.a.
Aim 5
To examine any association between the Bayley III
motor subscale and the motor classification score on the
NSMDA at 24 months c.a.
Hypothesis
H5a. Bayley III motor composite scores will correlate with
NSMDA motor classification scores at 24 months c.a.
Aim 6
To determine the extent to which environmental and
social factors including social risk, level of education,
incidence of postnatal depression and family strain will
be associated with neurodevelopmental and behavioural
outcomes at 16 weeks post-term and 24 months c.a.
Hypotheses
H6a. Early environmental and social factors identified
by a Social Risk Index (SRI), the Impact on Family Scale
(IOF-G) and the Edinburgh Post Natal Depression Scale
(EPDS), will have a predictive association with neurode-
velopmental outcome at 16 weeks post-term (AIMS,
GMs, Infant SP2) and at 24 months c.a (Bayley III,
NSMDA) as well as behavioural outcomes (Bayley III,
ITSEA) at 24 months c.a.
H6b. Higher social risk scores, lower maternal level of
education and incidence of maternal depression are
likely to be confounding variables for predicting cogni-
tive outcome on the Bayley III at 24 months c.a.
Aim 7
To evaluate the ability of perinatal variables, in particu-
lar brain injury on cranial ultrasound (CUS), intrauter-
ine growth restriction (IUGR), bronchopulmonary
dysplasia (BPD), necrotising enterocolitis (NEC), severe
retinopathy of prematurity (ROP), sex, g.a, late-onset
sepsis and breastfeeding status at discharge, to predict
mild motor and mild cognitive delay at 24 months c.a
(Bayley III, NSMDA). To further evaluate any predictive
association between perinatal variables and behavioural
outcomes and sensory profile at 24 months c.a (Bayley
III, Toddler Sensory Profile 2 (Toddler SP2), ITSEA).
Hypothesis
H7a. Perinatal factors including brain injury on CUS,
BPD, NEC, severe ROP, late-onset sepsis, g.a, sex and
breastfeeding status at discharge will predict neurodeve-
lopmental and behavioural outcomes at 24 months c.a
(Bayley III, NSMDA, Toddler SP2, ITSEA).
Aim 8
To determine any predictive relationship between
sensory processing profile (Infant SP2) at 16 weeks post-
term and sensory processing or motor profile at
24 months c.a (Toddler SP2, Bayley III).
Hypotheses
H8a. A typical sensory processing profile at 16 weeks
post-term on the Infant SP2 (infant total score <1SD
from the mean) will remain stable over time and predict
a typical sensory profile at 24 months c.a on the Toddler
SP2.
H8b. An atypical sensory processing profile at 16 weeks
post-term on the Infant SP2 (infant total score >2SD
from the mean) will be associated with an atypical
sensory profile at 24 months c.a on the Toddler SP2
(scores >2SD from the mean in any quadrant, sensory or
behavioural domain).
H8c. An atypical sensory processing profile at 16 weeks
post-term on the Infant SP2 (infant total score >2SD
away from the mean) will be associated with motor delay
at 24 months c.a on the Bayley III (motor composite
score 1SD or more below the mean).
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METHODS
Participants
Participants will be a prospective cohort of infants born
at <32 weeks and/or <1500 g admitted to the Special
Care Nursery (SCN), Nambour General Hospital
(NGH). Over a period of 24–36 months, 90 infants will
be entered into the study.
Inclusion criteria
Infants born at <1500 g and or <32 weeks gestation who
are admitted to the SCN and can be recruited prior to
37 weeks g.a.
Exclusion criteria
▸ Infants with major congenital or chromosomal
abnormalities.
▸ Families living outside a 100 km radius from the
NGH.
▸ Families where no English is spoken.
Sample size
The primary aim of this study is to use longitudinal tra-
jectories of GMs from 34 to 35 weeks gestation until
16 weeks post-term to predict typical or delayed neuro-
developmental outcome at 2 years c.a in very preterm/
VLBW infants. The GM Assessment was chosen as it is
the ‘gold standard’ measure for prediction of neurode-
velopmental outcome in this population.60
The expected ratio of normal to non-normal GMs
assessments is 3:1. This figure is derived from pilot data
collected in clinical practice at NGH, where a clinical
cohort of 86 preterm infants <32 weeks and/or <1500 g
was assessed using GMs at 34–35 weeks g.a and then at
2, 5, 11–12 and 16 weeks post-term. Fifty-nine infants
had normal GMs at each time point compared with 21
infants with at least one abnormal finding in their assess-
ment trajectory. Four infants were lost to follow-up.
The ability of GMs to predict neurodevelopmental
outcome (typical/delayed) was determined by calculat-
ing mean negative and positive predictive values (NPV
and PPV) from published studies with similar participant
characteristics and outcome measures. Two recent sys-
tematic reviews evaluating the predictive validity of the
GM Assessment were searched to find studies with com-
parable participants, measures and age at outcome.61 62
Only two studies with similar attributes were identi-
fied.63 64 A third study, identified in additional searches,
was also included65 (table 1).
Mean NPV and PPV were compared at each predictive
time point (preterm, writing and fidgety age; table 2).
The PS—Power and Sample Size Calculation Software
V.3.1.2, 2014 was then used to generate the sample size
calculations for preterm, writhing and fidgety ages using
α 0.01, power of 0.95 and a ratio of 3:1.
Results suggest that the predictive time point of
fidgety age (8–20 weeks) will require the largest sample
size to identify a statistically significant association
between GMs and neurodevelopmental outcome. Data
from the literature indicates that a normal GM result at
Table 1 Predictive values of GMs, NPV and PPV, with respect to neurodevelopmental outcome between 18 and 24 months
corrected age
Studies
included
Sample
size (n) Participants
Outcome measure and
age at outcome
Preterm
NPV (%)
Post-term
NPV (%)
Preterm
PPV (%)
Post-term
PPV (%)
Stahlmann
et al63
103 Preterm
infants
<1500 g
Motor outcome on the
Griffiths Developmental
Motor Scale at
20 months
*84 *89
Constantinou
et al64
102 Preterm
infants
<1500 g
Neurological
examination and Bayley
II scores at 18 months
90 *90 29 *41
Spittle et al65 94 Preterm
infants
<30 weeks
Cognitive outcome on
the Bayley III at 2 years
†94 *96 †14 *35
Language outcome on
the Bayley III at 2 years
†91 *93 †14 *35
Motor outcome on the
Bayley III at 2 years
†100 *96 †16 *35
*GMs at 3 months post-term, fidgety age.
†GMs at 1 month post-term, writhing age.
Bayley II, Bayley Scales of Infant and Toddler Development—Second Edition; Bayley III, Bayley Scales of Infant and Toddler Development—
Third Edition; GM, General Movement; NPV, negative predictive value; PPV, positive predictive value.
Table 2 Mean negative and positive predictive values
using GMs at three time points to predict typical or delayed
neurodevelopmental outcome in the second year of life
Time point Mean NPV Mean PPV
Preterm 90 29
2–7 weeks post-term—writhing 95 15
8–20 weeks post-term—fidgety 92 47
GMs, General Movements; NPV, negative predictive value; PPV,
positive predictive value.
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fidgety age leads to typical neurodevelopmental
outcome at 24 months c.a in 92% of infants. Assuming
that GMs at fidgety age correctly identify mild neurode-
velopmental outcomes at 24 months c.a in 47% of occa-
sions, we will need to collect data on 80 participants at
24 months c.a (20 with abnormal GM assessment and 60
with normal GM assessment) to demonstrate a statistic-
ally significant association between GM results at fidgety
age and TD and MDD at 24 months c.a.
By the nature of their design, longitudinal cohort
studies are vulnerable to participant attrition and
missing data; a potential cause of bias.66 In order to min-
imise any possible impact we will add an extra 10 partici-
pants (12.5%) into our study design and recruit a total
of 90 infants into the PREMTiME study.
Recruitment process
Infants will be enrolled in the study between 34 and
36 weeks g.a. An administrative staff member in the
SCN, not affiliated with the research project, will intro-
duce the study to parents or caregivers of infants who
meet eligibility criteria. If families are interested and
provide permission for contact, the principal investigator
or a member of the research team will supply a full
information pack including the parent information state-
ment. When providing the pack, a researcher, not asso-
ciated with the infant’s clinical care, will explain the
study in more detail and answer all parent questions
before seeking informed consent for study participation.
Once signed consent is obtained, the infant will be
enrolled in the study, parents will complete the relevant
forms and questionnaires, and the infant will receive the
relevant assessments.
Data collection methods
Data collection will start following consent and enrol-
ment (see figure 1 for study timeline). Perinatal data
will be collected by a member of the research team.
Primary caregivers will complete baseline questionnaires:
the EPDS, SRI and IOF-G.
Should a parent/caregiver score above 9 points on the
EPDS, a member of the research team will refer the
mother/caregiver to the SCN social worker. The social
worker will discuss the results with the parent/caregiver,
provide information about postnatal depression, explain
the need for further monitoring and request consent to
send a letter of notification to the carer’s general practi-
tioner (GP). Both the assessment findings and the
follow-up plan will be documented in the mother’s hos-
pital chart. An opportunity to monitor progress is
embedded within the study design. All mothers or
primary caregivers will repeat the test when their infant
reaches 45 weeks post-term.
Between 34 and 36 weeks g.a infants will be assessed
in the SCN using the P-NE and the GM Assessment. All
assessors will be masked to the identity, and medical
history of the infants. GMs and PN-E assessments will be
recorded using procedural guidelines developed by the
research team. The clinical photographer at NGH is
trained in the use of these guidelines. GM assessments
will be viewed and scored offline by two to four assessors
trained by the GM Trust.
After discharge, baseline data collection will occur
during four return appointments to the Allied Health
Paediatric Outpatient Clinic, NGH. At each visit, growth
trajectories will be monitored by recording body weight
and length. GMs will be videotaped by the NGH clinical
photographer while supervised by a member of the
research team and then viewed offline by expert assessors
masked to the infant’s identity, medical history, perinatal
data and previous assessment findings. The visits will be
timed for 2, 5, 11–12 and 16 weeks post-term providing
an opportunity for repeat assessment of GMs during both
the writhing and fidgety age. This may reduce the poten-
tial impact of missing data in the writhing age when
infants are occasionally too unsettled to complete video
assessment. Importantly, it meets the requirement for
assessment of fidgety movement on at least two occasions
to definitively classify GMs as absent fidgety.67
Additional data collection will occur at the 2, 5 and
16 weeks post-term appointments. At 2 weeks post-term,
infants will complete the NNNS. The assessment will be
administered by an NNNS accredited trainer masked to
the identity and medical history of the infant. The assess-
ment will be videotaped to allow offline scoring as
appropriate.
At 5 weeks post-term, the primary caregivers will
repeat the EPDS questionnaire. Should the caregiver
score above 9 on this occasion, a social worker will be
on site to discuss the results in session. The social
worker will recommend that the mother/caregiver seek
follow-up and consent will be sought to provide the GP
with the assessment findings. The assessment results and
negotiated health plan will be documented in the hos-
pital chart.
At 16 weeks post-term, an occupational therapist will
explain the Infant SP2 and provide parents with a copy
of the questionnaire to complete in session. A
physiotherapist will then administer the AIMS. Video
footage collected during the 16-week visit will include
both the GMs and the AIMS assessment allowing
masked assessors to view and score the assessments
offline. Following the 16-week post-term appointment,
infants will be categorised according to longitudinal tra-
jectories of GMs into low-risk, moderate-risk and high-
risk groups (table 3).
The outcome of all baseline assessments will be for-
warded in report format to the Paediatric Specialist
Outpatient Clinic, NGH, where a consulting paediatri-
cian will review all infants enrolled in the research
project between 18 and 20 weeks post-term. At this visit,
the paediatrician will have an opportunity to discuss
baseline assessment findings with parents or caregivers.
He/she may initiate referral to early intervention ser-
vices and organise any additional medical investigations
required. A request for MRI will be ordered by the
Caesar R, et al. BMJ Open 2016;6:e010726. doi:10.1136/bmjopen-2015-010726 7
Open Access
group.bmj.com on May 9, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
paediatrician in cases where infants are assessed as
absent fidgety on the GMs at 12 and 16 weeks.
Multidisciplinary case conferencing with the allied
health team will be organised for all infants identified as
high risk. The content and intensity of any concurrent
therapy received while enrolled in the PREMTiME
project will be documented by parents/caregivers in a
study calendar and measured in a parent recall question-
naire provided at study completion.
At 24 months c.a (±1 month), all participants will
attend two final appointments at NGH. Approximately
4 weeks prior, families participating in the study will
receive an appointment letter and the Toddler SP2 ques-
tionnaire to complete and return at the first appoint-
ment. Appointments will be scheduled within a 2-week
period. Children will be assessed by examiners masked
to the child’s identified level of risk, previous assessment
findings, medical history and perinatal data.
At the first appointment, children will receive the cog-
nitive, motor and language scales of the Bayley III and
the Toddler SP2 questionnaire will be scored. Caregivers
will be provided with the ITSEA to complete at home
Figure 1 Study time line of recruitment and assessment time points. P-NE, the Premie-Neuro Examination;49 51 g.a, gestational
age; GMs, General Movements Assessment; 91 EPDS, Edinburgh Post Natal Depression Scale;84 SRI, Social Risk Index;12 74
IOF, Impact of Family Scale;87–89 NNNS, Neonatal Intensive Care Unit Network Neurobehavioral Scale;52 Infant SP2, Infant
Sensory Profile 2;56 57 AIMS, Alberta Infant Motor Scale,100 Bayley III, Bayley Scales of Infant and Toddler Development—Third
Edition;109 NSMDA, Neuro-Sensory and Motor Developmental Assessment;59 ITSEA, Infant-Toddler Social Emotional
Assessment;119 Toddler SP2, Toddler Sensory Profile 2;56 57 ABAS III, Adaptive Behaviour Assessment Scale—Third Edition;116
c.a, corrected age.
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and return at the second session. Height and weight
measurements will be recorded.
At the second visit, parent/caregivers will complete
the Adaptive Behaviour Scales (ABAS III) and the Social
Emotional Scales of the Bayley III while a member of
the research team administers the NSMDA. Both the
Bayley III and NSMDA assessments will be video
recorded by the NGH clinical photographer.
All results of outcome assessment will be forwarded to
the child’s paediatrician at NGH, Paediatric Specialist
Outpatient Department. The paediatrician will review
each child within 1 month of study completion. At this
visit, final study results will be conveyed to the parents/
caregivers. Any diagnosis of CP will be documented,
defined and classified according to the Surveillance of
CP in Europe Network Guidelines and the Gross Motor
Function Classification Scale (GMFCS).68–72
Classification of motor type of CP and GMFCS will be
confirmed after review of video footage of the NSMDA
by independent expert assessors at the Queensland
Cerebral Palsy and Rehabilitation Research Centre
(QCPRRC).69 73
MEASURES AND PROCEDURES
Baseline measures
Perinatal data
An extensive record of antenatal and birth history and the
neonatal course will be collected from the Nambour
Hospital medical file at enrolment and then at discharge
from the SCN.74 75 Data collected will include primary
perinatal factors with known associations with neurodeve-
lopmental delay including early brain injury (intraventri-
cular haemorrhage identified on CUS or brain injury
identified on MRI), IUGR (weight <10th centile for g.a),
BPD (definition for infants born at <32 weeks g.a as per
criteria outlined by the National Institute for Health,
USA), ROP (classified by stages 1–5), severe NEC (requir-
ing surgery), late-onset sepsis (onset >48 hours postbirth),
preterm premature rupture of membranes, postnatal
infant steroid therapy and g.a at birth.1 9–11 76–82
NGH is a regional facility located 100 km north of the
nearest neonatal intensive care unit. Only a portion of
high-risk babies born or transferred from the Royal
Brisbane and Women’s Hospital (RBWH) will receive
MRI prior to transfer to Nambour. A summary of MRI
assessment findings will be included in transfer docu-
mentation and will be collected with perinatal data
when possible. All very preterm/VLBW infants will have
routine CUS at days 3, 7 and 42 of life at the RBWH
prior to transfer to NGH. Early CUS findings are rou-
tinely included in transfer documentation and graded
and reported according to the conventions outlined in
the Australia and New Zealand Neonatal Network
(ANZNN) data dictionary83 (see online supplementary
appendix 1 for a complete list of all perinatal variables
included in data collection).
Primary caregiver information
Edinburgh Post Natal Depression Scale
The EPDS is used to screen primary caregivers for risk
of postnatal depression. It is a 10-item self-reported scale
that takes 5 min to administer.84 Originally implemented
in the UK, it has since been validated for use in
Australia, demonstrating high sensitivity (100%) and spe-
cificity (89%) at a cut-off score of 12.5.85 The EPDS
appears to be acceptable to women as a screening instru-
ment with no complaints reported in an Australian study
of 4148 administrations carried out over 3 years.86
Facilitation of correct diagnosis is optimised by a
two-step strategy where those scoring above a predeter-
mined cut-off score on the first occasion have another
test readministered at a subsequent health visit.86 In
keeping with this evidence-based recommendation, the
EPDS will be used twice during this study. Primary care-
givers will complete the questionnaire at 34–36 weeks
and at 5 weeks post-term.
Clearly defined processes have been developed
around the event that a parent/caregiver scores above a
clinically conservative score of 9 points on the scale.
Researchers will ensure that caregivers are provided
timely support by a social worker, consent is sought to
inform their GP, women are encouraged to seek
follow-up and a negotiated health plan is documented
in the hospital chart.
Social Risk Index
A 12-point SRI will be used between 34 and 36 weeks g.a
to provide an overall social risk score for each
family.12 74 Families will be informed in the parent infor-
mation statement that all responses on the questionnaire
will be treated in a strictly confidential manner. The
index measures six aspects of social status:
1. Family structure (0—two caregivers (nuclear); 1—
separated parents with dual custody, or cared for by
other intact family; 2—single caregiver);
Table 3 Classification of neurodevelopmental risk
according to trajectory of longitudinal GMs between 34–35
weeks g.a and 16 weeks post-term
Level of
risk Method of classification
Low All normal GMs at preterm, writhing and
fidgety age
Medium At least one finding of abnormal movement
(poor repertoire or cramped synchronised) at
preterm or writhing age combined with either
normal fidgety or abnormal fidgety movement
at fidgety age.
High At least one finding of abnormal movement
(poor repertoire or cramped synchronised) at
preterm or writhing period combined with
absent fidgety movement at fidgety age.
g.a, gestational age; GMs, General Movements.
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2. Education of primary caregiver (0—tertiary educated;
1—11–12 years of formal schooling; 2—<11 years of
formal schooling);
3. Occupation of primary income earner (0—skilled/
professional; 1—semiskilled; 2—unskilled);
4. Employment status of primary income earner
(0—full-time employment; 1—part-time employment;
2—unemployed/pension);
5. Language spoken at home (0—English only; 1—some
English; 2—no English);
6. Maternal age at birth (0—more than 21 years; 1—18–
21 years; 2—<18 years).
Families will be categorised as lower social risk (score
≤1) or higher social risk (≥2).74
Revised IOF-G Scale
This questionnaire will be used between 34 and
36 weeks to assess the effect of a child’s illness, in this
case preterm birth, on the family system. The scale is an
easily administered, reliable and valid measure of a
family member’s perception of the effect of a child’s
chronic condition that can be used across diagnostic
groups.87–89 There are 15 items scored on a four-point
Likert scale (strongly agree to strongly disagree) that
take 10 min to complete. It can be used either as a ques-
tionnaire or read to the family if needed.87–89
Infant assessments
The Premie-Neuro Examination
The PN-E is a new assessment tool designed in response
to the relative scarcity of effective neurological assess-
ments available for the extremely low birth weight and
VLBW infant.49 51 It is a standardised clinical neurological
and neurobehavioural examination designed to assess
brain function in fragile VLBW/very preterm infants
from birth until 37 weeks of gestation.49 The test is specif-
ically designed to minimise the impact of handling and
can be modified for infants <28 weeks. It can be done
while the baby is still in an isolette and electronically
monitored and can be completed within ∼10 min.
The test is administered between 30 min and 1 hour
before a scheduled feed and takes 10–15 min to com-
plete. It consists of three subscales: Neurological,
Movement and Responsiveness—each with eight items.
Early research indicates good construct validity with
good internal consistencies of the three subscales
(Cronbach’s α 75, 0.73 and 0.82). There is evidence of
predictive capability with raw scores at 34–36 weeks c.a
able to discriminate between high-risk and low-risk
groups of infants at term age and predict outcome on
the AIMS at 3 months c.a.46 49 51 In keeping with these
findings infants in this study will have the PN-E adminis-
tered between 34 and 36 weeks g.a.
It is acknowledged that the PN-E has less published
evidence for prediction than other preterm assessments
such as the Dubowitz Neurological Assessment or the
Test of Infant Motor Performance (TIMP). The
Dubowitz was not included in this study as its predictive
capability for normal outcomes is relatively modest and
the primary aim of this study is to predict typical
outcome.90 The TIMP has moderately better predictive
validity for outcome than the Dubowitz but less clinical
utility than the PN-E.45 48 The TIMP takes up to 40 min
to administer while scoring 42 items, the majority of
which are elicited. This is not suited to many fragile
preterm infants <36 weeks of age and does not fit well
within the ethos of a SCN where nursing and medical
staff aim to keep handling and cares to a bare
minimum.
As the PN-E has high clinical utility with early indica-
tions of useful clinical validity, it has potential for use as
a very early biomarker of neurodevelopmental risk.
Further research is required to determine test reliability
in the clinical setting, to determine concurrent validity
with other early neuromotor assessments (specifically
GMs) and to further determine predictive validity.51 All
P-NE assessments will be video recorded to increase
accuracy of measurement, especially on observational
items. Our own inter-rater reliability will be determined
as part of the study using a subsample of 20 infants.
Prechtl’s Method of Qualitative Assessment of GMs
The GM Assessment is a predictive and discriminative
tool that involves longitudinal observations of the
infant’s spontaneous motor activity.45 91 GMs have high
specificity (96%) and sensitivity (95%) for predicting CP
and early evidence suggests they have potential to
predict normal or milder neurodevelopmental out-
comes.61 62 92–95 GMs are assessed from preterm until
20 weeks c.a. The assessment is carried out by videoing
the infant in a calm alert state, without external stimula-
tion. In the early preterm stage, this may require up to
an hour of video recording but after the infant reaches
term age, 5 min is the minimum requirement.
Examiners must determine if spontaneous movement
is fluent, variable and complex before defining GMs as
normal or abnormal.91 Normal GMs in the preterm
period are gross movements involving the whole body,
including arm, leg, neck and trunk movements in vari-
able sequence. They ‘wax and wane’ in intensity, force
and speed and have a gradual beginning and end.91
From 40 weeks until ∼8 weeks post-term movements are
classified as ‘writhing’ in nature. Normal writhing move-
ments are characterised by small-to-moderate amplitude
and by slow-to-moderate speed and are elliptical in
form. Abnormal movements during the both the
preterm and writing periods are described as poor rep-
ertoire, chaotic or cramped synchronised.91
Between 6 and 9 weeks post-term and continuing until
∼20 weeks c.a, GMs change to a ‘fidgety’ pattern and
are defined as “circular movements of small amplitude
and moderate speed and variable acceleration, of neck,
trunk, and limbs, in all directions”.91 They are continual
in the awake infant, except during focused attention,
fussing and crying. The infant will score as normal when
fidgety movements are present. Abnormal movement is
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scored when fidgety movements are absent or abnormal
in pattern. Assessment at more than one time point
during the fidgety age is necessary to definitively score
an infant as absent fidgety.67 The infants in this study
will have GMs assessed at 34–36, 2, 5, 11–12 and
16 weeks post-term.
Neonatal Intensive Care Unit Network Neurobehavioral Scale
The NNNS is a non-invasive clinical tool developed to
assess neurobehaviour of ‘at-risk’ infants and is suitable for
use with very preterm/VLBW infants.52 96 The assessment
takes between 15 and 20 min to administer, ideally in a
quiet, dimly lit room, 2 hours after feeding. The examin-
ation is state-dependent with a standardised format. It
assesses the full range of infant neurobehavioral perform-
ance including neurological integrity, behavioural func-
tioning and signs of stress/abstinence.52 96
Test items are presented in 13 packages providing
summary scores/subscales for habituation, attention,
handling, quality of movement, regulation, non-optimal
reflexes, arousal, hypertonicity, hypotonicity, asymmetrical
reflexes, excitability and lethargy.52 96 The NNNS has good
internal consistency for item summary scores (Cronbach’s
α 0.87–0.90).97 Published norms are available for summary
scores of healthy term-born infants at term age (n=344)
and for summary scores of very preterm infants at
1 month c.a (n=204, 24–32 weeks g.a).97 98
Evidence for prediction of motor and cognitive out-
comes in very preterm and VLBW populations is
good.53 54 99 Summary scores at term c.a in a sample of
41 VLBW infants were predictive of motor and cognitive
outcomes on the Bayley Scales of Infant and Toddler
Development—Second Edition (Bayley II) at 18 months
c.a.53 In another study of 1248 infants <37 weeks gesta-
tion, profiles of summary scores (profiles 1–5) were cal-
culated and used to predict outcome from birth to
4.5 years. At 1 month c.a, infants with a profile of five
were more likely to have impaired Bayley II mental and
psychomotor developmental index scores at 2 years c.a;
chronic neurological abnormalities and brain-related
illness or CP and behaviour problems at 3 years; motor,
concept and language problems in school readiness at
age 4 years; and lower IQ at 4.5 years.54 The NNNS will
be used to assess infant neurobehaviour at 2 weeks c.a.
Alberta Infant Motor Scale
The AIMS is a discriminative, norm referenced tool that
tests gross motor skills through the components of weight
bearing, posture and antigravity movements.100 101 The test
takes 20 min to administer and involves observation of the
infant in prone, supine, sitting and standing. The AIMS is
an appropriate assessment tool for monitoring the gross
motor development of typically developing infants and has
normative data based on a population of 2200 infants from
0 to 18 months in Alberta, Canada.102 Normative data for
preterm infants has also been published with a sample of
800 infants born at <32 weeks from the Netherlands.103
The AIMS has excellent inter-rater, intra-rater and
test–retest reliability for full-term and preterm
infants.104 105 The AIMS has excellent reliability,
content, construct and concurrent validity with the
BSID-II (r=0.98).100 103 105 Although the AIMS was not
designed as a predictive tool, it has good predictive vali-
dity at 4 months for developmental outcome at
18 months (sensitivity 77.3%, specificity 81.7%).106 The
AIMS will be used to classify each infant’s development
as normal or suspicious/abnormal at 56 weeks g.a using
cut points at the 10th centile on the term percentile
scale and the 25th centile on the premature infant per-
centile scale.100 102
Sensory Profile 2
The SP2 is a newly revised edition of the ITSP.56 57 It is a
standardised tool used to evaluate a child’s sensory pro-
cessing patterns in the context of participation. It
enables professionals to gather information about the
child’s sensory processing abilities and how those pat-
terns either support or interfere with functional per-
formance.58 It is based on a sensory integration and
neuroscience frame of reference and the author’s
model of sensory processing.107 108
The tool supports family-centred practice by actively
engaging the primary caregiver in the data gathering
process.108 Primary caregivers observe the infant or child
engaging in a number of different environmental contexts
at home or other community settings and then report on a
range of behaviours on the item scoring sheet. The esti-
mated time for completion is 5–20 min based on the care-
giver completing the questionnaire in one sitting.
The SP2 was standardised between 2012 and 2013
using a normative sample of 1791 participants and a
clinical sample of 771.56 57 Where previously only raw
scores were calculated, the new version allows percentile
ranking of infant total scores as well as quadrant scores
for toddlers and older children. Reliability of the
measure is overall good to very good (internal consist-
ency 0.63–0.93, parent test–retest 0.83–0.97, inter-rater
reliability 0.49–0.9/mostly >0.7).56 Correlation between
the ITSP and the SP2 is moderate-to-high.56 57
The new edition has several other improvements and
advantages compared with the ITSP.56 57 The required
reading level is grade 6 equivalent and parents have the
option to complete the forms online. In addition, the
questionnaire is now presented in two separate user-
friendly forms for infants and for toddlers. The Infant
SP2 is used for babies from birth to 6 months and will
be used as a baseline measure at 16 weeks post-term.
The Toddler SP2 is for ages 7–35 months. It will be used
as an outcome measure at 24 months c.a.
Outcome measures
The Bayley Scales of Infant and Toddler Development—
Third Edition
This assessment is a relatively new revision of the Bayley
II. It is a norm-referenced, discriminative measure used
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to describe the current developmental functioning of
the infant with good to strong validity and reliability.109
Other possible uses of the test include identification of
possible developmental delay, identification of relative
strengths and weaknesses, monitoring of developmental
progress and prediction of cognitive function at pre-
school entry.110 The third edition consists of five distinct
scales: Cognitive, Language, Motor, Social-Emotional
and ABAS II. All five scales will be utilised in this study.
Assessment is individually administered and may take up
to 90 min to complete. Caregivers are encouraged to
remain present but not to influence the test
proceedings.
Several recent studies recommend the precautionary
use of a term-born control group and/or different cut
points when using the Bayley III as a primary outcome
measure.111–114 Studies conducted in Australia and the
USA have found that significantly fewer infants are iden-
tified with neurodevelopmental delay with the Bayley III
when compared with previous findings using the Bayley
II.112 113 Several explanations are possible but it is still
unclear whether the Bayley III is overestimating develop-
mental performance, whether it is a more valid assess-
ment of neurodevelopmental impairment than the
Bayley II or if premature infant outcomes are improving.
In keeping with these recommendations, scores
obtained in this cohort of very preterm/VLBW infants
will be compared with published reference data of an
Australian cohort of 202 term-born controls.112
The ABAS II is one of the five subscales in the Bayley
III.109 Adaptive behaviour is defined as the collection of
conceptual, social and practical skills that have been
learned by people in order to function in their everyday
lives.115 A newly revised edition, the ABAS III is now
available for use.116 Retaining all of the essential features of
the ABAS II, the new edition is even easier to administer
and score. It is a parent-reported, norm-referenced and
standardised measure of adaptive skills measuring a child’s
functioning ability in the areas of Communication,
Community Use, Health and Safety, Leisure, Self-Care,
Self-Direction, Functional Pre-Academics, Home or School
Living, Social, Work and Motor.
The ABAS III takes 15–20 min to complete. Caregivers
rate the extent to which their child performs the adap-
tive skill when needed using a four-point reference
scale. Norm-referenced scaled scores are used to inter-
pret results in the skills area and norm-referenced stand-
ard scores, CIs for standard scores, and percentile ranks
are used to rate performance across the three adaptive
domains and calculate a General Adaptive Composite
Score.116 The ABAS III builds on the ABAS II which has
strong psychometric properties with good to excellent
content validity, test–retest reliability and internal
consistency.115
The Neuro-Sensory and Motor Developmental Assessment
This a discriminative and predictive criterion referenced
measure with a functional grading system that scores
overall motor performance classification as normal, mild
not impacting function, mild, moderate, severe or pro-
found impairment.59 117 It measures gross motor, fine
motor and sensory motor development, neurological
status and postural control. The examiner observes and
administers items and the test takes up to 30 min to
complete. A published study of 148 preterm infants
demonstrates adequate construct validity with the
NSMDA able to discriminate between normal and
abnormal outcome at 24 months c.a.45 118 Concurrent
validity has been reported in relation to agreement with
paediatric classification of normal or atypical develop-
ment at 24 months c.a (χ2=0.08).45 118 Reliability has
only been reported in terms of correlation (r=0.80).45
The Infant Toddler Social-Emotional Assessment
The ITSEA is a comprehensive parent-reported instru-
ment for evaluating behavioural problems and social
emotional competencies in infants aged 12–36
months.119 The complete ITSEA includes 166 items that
are rated on a three-point scale: (0) not true/rarely, (1)
somewhat true/sometimes and (2) very true/often. A ‘no
opportunity’ code allows parents to indicate that they
have not had the opportunity to observe certain beha-
viours. If reading levels are inadequate, it can be pre-
sented in interview format without impeding test
reliability.119
The test measures four broad domains of behaviour:
externalising, internalising, dysregulation and competen-
cies. Three additional indices: maladaptive, atypical
behaviour and social relatedness are used to aid identifi-
cation of significant psychopathology including
attention-deficit hyperactivity disorder or autistic spec-
trum disorder.119 Test construct, reliability and validity
was examined in a population sample of 1235 parents of
children.119 The test has good internal consistency
across all four major domains, good validity, and accept-
able test–retest and inter-rater reliability.45 119
DATA ANALYSIS PLAN
Analysis will be carried out using R V.2.9.1 with the
R-Commander and R Studio statistical analysis packages.
Predictor and outcome variables will be identified as
continuous or categorical. Initial analysis will explore
the distributions, means and variability of continuous
variables and the rate of occurrence and distribution of
categorical variables. Any outlying data will be identified
and the characteristics of any missing data explored.
Graphical representations (histograms, boxplots and
scatter plots), tables of means and SD and cross tabula-
tions will be used to understand any relationships
between variables.
Univariable regression analysis will be used to deter-
mine any associations between predictor and outcome
variables. A forward selection process, entering variables
one-by-one, will help to determine any confounding
pathways. Multivariable analysis will be performed to
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understand major contributors and the effect of con-
founders. Generalised estimating equations (GEEs) will
be included to determine the extent that early assess-
ment will predict later outcomes of interest.120 GEEs
track the importance of potential predictor variables
over time, accounting for the dependence of observa-
tions recorded from the same participant. Consideration
will be given to any non-linear effects and interactions.
A scaled score of the baseline assessment measures
will be used to determine the sensitivity, specificity, PPV
and NPV of early biomarkers to predict typical outcome
and MDD at 24 months c.a. Typical outcome will be
defined as motor and cognitive scores that are above
1SD below the mean on the Bayley III and a functional
grade of 1 or 2 on the NSMDA. Developmental delay
will be defined as motor and cognitive scores 1SD or
more below the mean on the motor and cognitive sub-
scales of the Bayley III and a functional grade >2 on the
NSMDA.
DISCUSSION
As families, clinicians and health services continue to
want and need more immediate information regarding
the short-term and long-term outcomes of at-risk infants,
finding the best clinical biomarkers has the potential to
streamline and effectively prioritise premature infant
follow-up programmes.
Results of this study will inform health policy and
service delivery of follow-up pathways and early interven-
tion for very preterm/VLBW infants and their families
and guide the provision of targeted, evidence-based
service delivery in clinical settings. Findings will be of
interest to medical, allied health, nursing staff, hospital
and health service districts.
Findings will also inform future studies with the intent
to follow this cohort of very preterm/VLBW infants until
completion of the Queensland Studies Authority, Grade
2 Diagnostic NET test. The Diagnostic NET test is a
monitoring and assessment programme of literacy and
numeracy competencies administered state wide and typ-
ically undertaken at 7 years of age in Queensland
schools.121
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